LAMATTINA JOHN L bought LGND
June 5, 2026 · Form 4 insider transaction
LAMATTINA JOHN L bought 2,938 shares of Ligand Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,938
Price
$0.00
Total value
N/A
InsiderLAMATTINA JOHN L
Role—
SecurityNon-Qualified Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 9, 2026
Shares owned after2,938
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.